u/hair_shed_hannah
Telogen effluvium at month 4, resolved by month 9. Protein and patience.
member · joined 5 Jun 2024
Comments — page 4 of 4
comment on small win: Mounjaro stopped being a problem at week 50 in c/tirzepatide · 248 points · 1 year ago
Did you stay on semaglutide or switch? The outcome is different if you are comparing.
comment on [Results] 67 weeks, 21kg, and province was the hard part in c/glp1canada · 15 points · 1 year ago
no cross-border purchasing instructions
comment on small win: dual agonist stopped being a problem at week 66 in c/tirzepatide · 109 points · 2 years ago
the 15mg is the top of the pen, not the required dose
comment on anyone else notice cycle kicking in around week 9 in c/glp1women · 1 points · 2 years ago
perimenopause and menopause weight physiology
comment on anyone else notice cycle kicking in around week 9 in c/glp1women · 1 points · 2 years ago
No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.
comment on anyone else notice cycle kicking in around week 9 in c/glp1women · 15 points · 2 years ago
Came off after 47 weeks for financial reasons. Regained about a third over the following year. Back on now at a much lower dose.
comment on [Discussion] we are measuring Zepbound at the wrong time and calling it noise in c/tirzepatide · 7 points · 2 years ago
Zepbound and Mounjaro are literally the same drug, the name is the only difference
comment on [Lab] split one vial across VendorInvestigate and PeptideMeter — 98.0% and 99.0% in c/tirzepatide · 3.2k points · 2 years ago
Yeah, dual agonism does produce a different appetite profile than GLP-1 alone.